Novavax | NVAX - DEBITO





DEBITO Cambiamento Data
Adma Biologics USD 83.12M 702K 2025-09
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Cassava Sciences USD 0 0 2024-12
Geron USD 121.92M 73K 2025-09
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
MannKind USD 119.91M 73.09M 2025-09
Merck USD 49.34B 7.97B 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.31B 571M 2025-12
Novartis USD 32.02B 615M 2025-09
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.96B 3.11B 2025-12
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09